Seminars in Liver Disease

LinksSchließen

Referenz

Ronot M, Bouattour M, Wassermann J. , et al.
Alternative response criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib.

Oncologist 2014;
19 (04) 394-402

Bibliographische Angaben herunterladen

Aufrufen in: